Xiaolin Lü

机构：Harbin Medical University, Sun Yat-sen University, Kunming Medical University, Shantou University, Wuhan University, Fudan University Shanghai Cancer Center, Third Affiliated Hospital of Harbin Medical University, Capital Institute of Pediatrics, Gannan Medical University, First Affiliated Hospital of Shantou University Medical College, Yan'an Hospital Affiliated To Kunming Medical University, First People's Hospital of Jingzhou, The Second Affiliated Hospital of Xiamen Medical College, Shanxi Datong University · ORCID：0000-0002-6858-7587

发表论文 172 篇 · 总被引 3166 次 · h-index 30

代表论文

• Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD‐mediated pyroptosis in colorectal cancer (2024 · Clinical and Translational Medicine · 被引 51)
• TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1‐Mediated Arachidonic Acid Metabolism (2024 · Advanced Science · 被引 19)
• Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic (2024 · Heliyon · 被引 19)
• Trace-Amount Detection of Chiral Molecules Based on Plasmonic Racemic Arrays Fabricated via Direct Laser Writing (2024 · ACS Sensors · 被引 15)
• Deterministic Placement of Achiral Emitters in Superchiral Fields for Superior Chiral Photoluminescence (2025 · Nano Letters · 被引 11)
• Polarization‐Directed Construction of 3D Spiral Plasmonic Micropillars for Enhanced Chiral Photoluminescence (2025 · Laser & Photonics Review · 被引 7)